Carbon ion radiotherapy for prostate cancer with bladder invasion

[1]  T. Bathala,et al.  Management of cT4 Prostate Cancer. , 2020, European urology focus.

[2]  H. Ishikawa,et al.  Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702” , 2020, BMC Cancer.

[3]  Z. Ye,et al.  The role of cystoprostatectomy in management of locally advanced prostate cancer: a systematic review , 2020, World journal of surgical oncology.

[4]  Xiujun Cai,et al.  Survival benefits of neoadjuvant chemo(radio)therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta-analysis , 2019, World Journal of Surgical Oncology.

[5]  N. Tohyama,et al.  Current status of intensity‐modulated radiation therapy for prostate cancer: History, clinical results and future directions , 2019, International journal of urology : official journal of the Japanese Urological Association.

[6]  F. Schumacher,et al.  Comparative Effectiveness of Local and Systemic Therapy for T4 Prostate Cancer. , 2018, Urology.

[7]  M. Stoeckle,et al.  Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: results of a single‐institution series with long‐term follow‐up , 2018, BJU international.

[8]  Mahul B Amin,et al.  Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2017, The American journal of surgical pathology.

[9]  H. Ishikawa,et al.  Significant impact of biochemical recurrence on overall mortality in patients with high‐risk prostate cancer after carbon‐ion radiotherapy combined with androgen deprivation therapy , 2016, Cancer.

[10]  H. Tsujii,et al.  Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks , 2014, British Journal of Cancer.

[11]  M. Silverstein,et al.  DCIS Treated with Excision Alone Using the National Comprehensive Cancer Network (NCCN) Guidelines , 2013, Annals of Surgical Oncology.

[12]  Tohru Okada,et al.  Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractions. , 2012, International journal of radiation oncology, biology, physics.

[13]  P. Hoskin,et al.  Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  V. Master,et al.  Stage IV prostate cancer: survival differences in clinical T4, nodal and metastatic disease. , 2010, The Journal of urology.

[15]  T. Habuchi,et al.  Cystoprostatectomy as a Treatment of Prostate Cancer Involving the Bladder Neck , 2009, Urologia Internationalis.

[16]  Tatsuaki Kanai,et al.  Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  Paul Schellhammer,et al.  Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. , 2006, International journal of radiation oncology, biology, physics.

[18]  Tatsuaki Kanai,et al.  Hypofractionated radiotherapy with carbon ion beams for prostate cancer. , 2005, International journal of radiation oncology, biology, physics.

[19]  L. Egevad,et al.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.

[20]  S Minohara,et al.  Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. , 1999, International journal of radiation oncology, biology, physics.

[21]  Margie Hunt,et al.  Intensity-modulated radiation therapy: supportive data for prostate cancer. , 2008, Seminars in radiation oncology.

[22]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..